Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01356056 · ClinicalTrials.gov registry record
Tele-diagnostics for Remote Parkinson's Monitoring
A clinical trial, sponsored by Great Lakes NeuroTechnologies.
- Completed
- Registry status
- 12
- Enrollment target
NCT01356056: Completed study, sponsored by Great Lakes NeuroTechnologies.
NCT01356056 is a clinical trial that has completed, run by Great Lakes NeuroTechnologies. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01356056 has completed, sponsored by Great Lakes NeuroTechnologies.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The purpose of this research study is to design, implement, and clinically assess a portable, user worn system for monitoring Parkinson's disease (PD) motor symptoms. The current standard in evaluating symptoms is the Unified Parkinson's Disease Rating Scale (UPDRS), a subjective, qualitative ranking system. The main goal of this research is to develop a quantitative system, Kinesia HomeView, to assess tremor as well as different features of bradykinesia in a home based system which can capture those symptom changes over the course of a day and aid in evaluating treatment protocol efficacy.
Interventions
- DEVICE Kinesia HomeView
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2011-05 |
What the finished NCT01356056 record still lists
NCT01356056 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Kinesia HomeView is the first listed.
NCT01356056 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01356056 about?
NCT01356056 is a clinical study titled "Tele-diagnostics for Remote Parkinson's Monitoring". The purpose of this research study is to design, implement, and clinically assess a portable, user worn system for monitoring Parkinson's disease (PD) motor symptoms. The current standard in evaluating symptoms is the Unified Parkinson's Disease Rating Scale (UPDRS), a subjective, qualitative rankin...
What is the current status of trial NCT01356056?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2011-05.
What interventions are being tested in trial NCT01356056?
The interventions under investigation include: Kinesia HomeView (DEVICE).
Who is sponsoring clinical trial NCT01356056?
This trial is sponsored by Great Lakes NeuroTechnologies, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia